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Background: Myocardial infarction (MI) documented by late gadolinium enhancement (LGE) has clinical and
prognostic importance, but its detection is sometimes compromised by poor contrast between blood and MI.
MultiContrast Delayed Enhancement (MCODE) is a technique that helps discriminate subendocardial MI from blood
pool by simultaneously providing a T2-weighted image with a PSIR (phase sensitive inversion recovery) LGE image.
In this clinical validation study, our goal was to prospectively compare standard LGE imaging to MCODE in the
detection of MI.
Methods: Imaging was performed on a 1.5 T scanner on patients referred for CMR including a LGE study.
Prospective comparisons between MCODE and standard PSIR LGE imaging were done by targeted, repeat imaging
of slice locations. Clinical data were used to determine MI status. Images at each of multiple time points were read
on separate days and categorized as to whether or not MI was present and whether an infarction was transmural
or subendocardial. The extent of infarction was scored on a sector-by-sector basis.
Results: Seventy-three patients were imaged with the specified protocol. The majority were referred for vasodilator
perfusion exams and viability assessment (37 ischemia assessment, 12 acute MI, 10 chronic MI, 12 other diagnoses).
Forty-six patients had a final diagnosis of MI (30 subendocardial and 16 transmural). MCODE had similar specificity
compared to LGE at all time points but demonstrated better sensitivity compared to LGE performed early and
immediately before and after the MCODE (p = 0.008 and 0.02 respectively). Conventional LGE only missed cases of
subendocardial MI. Both LGE and MCODE identified all transmural MI. Based on clinical determination of MI, MCODE
had three false positive MI’s; LGE had two false positive MI’s including two of the three MCODE false positives. On a
per sector basis, MCODE identified more infarcted sectors compared to LGE performed immediately prior to
MCODE (p < 0.001).
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Conclusion: While both PSIR LGE and MCODE were good in identifying MI, MCODE demonstrated more
subendocardial MI’s than LGE and identified a larger number of infarcted sectors. The simultaneous acquisition of
T1 and T2-weighted images improved differentiation of blood pool from enhanced subendocardial MI.
Keywords: Late gadolinium enhancement, Myocardial infarction, MultiContrast Delayed Enhancement,
Cardiovascular magnetic resonanceBackground
The introduction of late gadolinium enhancement (LGE)
as a means to identify myocardial infarction (MI) and
predict recovery of left ventricular systolic function was
a key factor in pushing cardiovascular magnetic reson-
ance (CMR) into mainstream clinical use [1]. The ability
to accurately detect MI, as well as characterize the trans-
mural and circumferential extent of infarction, plays an
important role in assessing viability.
MI as documented by LGE has prognostic significance
[2,3]. Atypical patterns of LGE within cardiomyopathic
processes such as hypertrophic cardiomyopathy and
nonischemic dilated cardiomyopathy are also thought to
be associated with arrhythmias [4,5], as well as increased
mortality [6].
To improve clinical workflow efficiency, many imaging
sites perform LGE imaging [1,7] approximately 10 min
after administering gadolinium contrast. However, the
contrast between the blood pool and infarction may not
be optimal so early after contrast administration [8]. There
is a concern that lack of contrast at the tissue-blood inter-
face on LGE images could increase the rate of false nega-
tive LGE images in the detection of subendocardial MI.
MultiContrast Delayed Enhancement (MCODE) [9] is
a CMR technique designed to help discriminate suben-
docardial MI from blood pool. The MCODE sequence
generates both a T2-weighted image and a T1-weighted
LGE image during the same breath-hold and at the same
phase of the cardiac cycle. The resultant image pair can
be displayed side-by-side or superimposed. Myocardium,
whether normal or infarcted, can be differentiated from
fluid using T2 contrast, which is minimally affected by
the presence of gadolinium contrast agents when a se-
quence with negligible T1-weighting is employed. The
T2-weighted image depicts infarcted and viable myocar-
dial tissue with similar signal intensity, and both have
better contrast with the blood pool.
In this clinical validation study, our goal was to pro-
spectively assess whether the T2- weighted image
acquired during an MCODE acquisition adds diagnostic
value to the LGE images. We hypothesized that MCODE
should significantly decrease false negative LGE images
for diagnosing MI in both acute and chronic MI when
contrast between blood and infarct is poor and the
transmural extent of infarction is subendocardial.Methods
The study was approved by the Institutional Review
Board, and all subjects provided informed consent. Im-
aging was performed on either a 1.5 Tesla Siemens
Espree or Avanto MRI scanner (Siemens Medical, Erlangen,
Germany). Seventy-three patients with a variety of diagno-
ses referred for CMR that included LGE were imaged (37
stress, 22 viability, 12 other). Patients with hypertrophic
cardiomyopathy were excluded from analysis (n=2). Clinical
data were obtained through patient history and medical
records. Patients were categorized as having an MI if they
had: 1) a history of an acute chest pain syndrome
with associated abnormal cardiac enzyme elevation
2) evidence of MI by Q waves on EKG with angio-
graphically significant coronary artery disease or an
abnormal nuclear perfusion study, or 3) fixed perfu-
sion defect on a nuclear study. Other patients were
categorized as not having an MI.
Image acquisition
All patients underwent cine imaging of the heart, using
steady-state free precession techniques in a volumetric
short-axis stack with standard three-, two-, and four-
chamber long axis views. Typical parameters for the cine
imaging included a matrix size of 256 × 144, slice thick-
ness of 6mm, TE 1.65, bandwidth of 977 Hz/Px, and a
flip angle of 50°. After administration of 0.15-0.2 mmol/
kg gadolinium-diethylenetriamine pentaacetic acid (Gd-
DTPA) (Magnevist, Berlex, Wayne, New Jersey, United
States), a stack of short-axis and three standard long axis
LGE images were acquired using a phase sensitive inver-
sion recovery (PSIR) [10] spoiled gradient recalled echo
sequence. The typical parameters were a matrix size of
256 × 144, 6mm slice thickness, TI individualized to null
the myocardium, TE 3.25msec, TR 8.2 ms, bandwidth of
140 Hz/pixel, and an excitation flip angle of 25°. PSIR
LGE was a breath-held, ECG triggered, segmented ac-
quisition with inversions every 2 R-R intervals, acquiring
a proton density (PD) weighted image on alternate
heartbeats. Typical segmentation was 21 phase encode
lines per heartbeat at a nominal 60 beats per minute
heart rate, corresponding to a breath-hold duration of
10 heartbeats including 2 discarded beats.
Prospective comparisons between MCODE and stand-
ard PSIR LGE imaging were done by targeted, repeat
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image was obtained, followed by an MCODE acquisition
and another standard PSIR LGE image on three sequen-
tial breath holds. The rationale behind repeating the
standard PSIR LGE imaging was to minimize differences
in image contrast attributable to renal clearance and
therefore primarily compare the MCODE LGE T1 and
T2 images with conventional PSIR LGE. The MCODE
acquisition resulted in PSIR LGE and T2-weighted
images within the same breath-held acquisition. Typical
imaging parameters of the MCODE sequence included a
matrix of 256 × 119, corresponding to a spatial reso-
lution of 1.3 × 2.3 mm2 for a nominal 360 × 270 mm2
field of view, slice thickness 6 mm, TI optimized on an
individual basis (but commonly 300 ms), TE 2.47 ms, TR
6.4 ms, BW 201 Hz/pixel, spoiled GRE read-out, excita-
tion flip angle 25° for the T1-weighted PSIR LGE image
and 15° for the T2-weighted image. MCODE was a
breath-held, ECG triggered, segmented acquisition with
inversions every 3 R-R intervals, acquiring an IR, PD,
and T2-weighted image on alternate heartbeats. Typical
segmentation was 30 phase encode lines per heartbeat at
a nominal 60 beats per minute heart rate, corresponding
to a breath-hold duration of 15 heartbeats including 3
discarded beats. The effective TE for the T2-weighted
images was 40 ms. Using the segmented FLASH read-
out leads to a minor T1-weighted contrast which hasPSIR LGE T1 data
Proton 
referen
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Figure 1 Simplified schematic of what data is acquired in MCODE: Wi
and a T2-weighted image at similar time points in the cardiac cycle. T
normal myocardium and bright MI. The T2-weighted image easily different
T1-weighting. Thus, the MI looks comparable to viable myocardium, and th
indicate the location of a MI on both the LGE T1 image (left) and the T2-wbeen found to be negligible for this application of dis-
criminating blood pool from myocardium [9]. Figure 1
illustrates a simplified schematic of the data acquired
with MCODE. The red arrows indicate an inferior wall
MI that has poor infarct to blood pool contrast on the
LGE T1 image on the left. In the same region, on the
right panel, the red arrows point to where the subendo-
cardial blood pool interface is clearly seen.
Image analysis
Each image, within the standardized image set - the ini-
tial late gadolinium enhancement images (LGE1), the
repeated late gadolinium enhancement images (LGE2),
the MCODE (containing a PSIR LGE image and a T2-
weighted image), and the third late gadolinium enhance-
ment images (LGE3) - were read on different days from
other images of the same patient by a single Level III
cardiovascular magnetic resonance imaging cardiologist
with over 10 years’ experience. All PSIR LGE images
were categorized as to whether or not MI was present
and whether a MI was transmural (>50 of the trans-
mural extent of the myocardium) or subendocardial
(≤50% the transmural extent of the myocardium). The
MCODE images were reviewed independently from the
standardly acquired LGE images. During the MCODE
analysis, the LGE and T2 images were reviewed both
side by side, as well as in a superimposed “flicker”-mode.T2 data
density
ce image 
T2 Prep
thin the same acquisition, MCODE produces both a LGE T1 image
he LGE image is comparable to conventional methods with nulled,
iates fluid (blood) from solid tissue (myocardium) but has minimal
e endocardium is better delineated than on LGE images. Red arrows
eighted image (right).
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performed. The number of sectors with MI on LGE2
and the MCODE LGE/T2 image pair were individually
tallied to determine the extent of the infarction. In all
patients with MI, on the MCODE LGE T1 image,
regions of interest were drawn within normal myocar-
dium, around myocardial infarction, and within the
blood pool. From the T1 image, the same regions of
interest for the normal myocardium and MI were copied
and applied to the MCODE T2 image. Signal intensities
were reported as mean ± standard deviation.
Statistical analysis
Statistical significance was analyzed using MedCalc Ver-
sion 12.0.1 statistical software (MedCalc Software,
Mariakerke, Belgium). Descriptive data are reported as
mean ± standard deviation (SD) if data were normally
distributed or median with interquartile range if not nor-
mally distributed. A D’Agostino Pearson test was used to
determine if continuous data were normally distributed.
A t-test was used to compare mean values of normally
distributed data. A Wilcoxon test was used to compare
paired categorical data or data that were not normally
distributed. A McNemar test was used to compare pairs
of correlated proportions. A Friedman test was used to
detect differences in repeated measures for data that
were not normally distributed. A Mann–Whitney test
was performed on unpaired categorical data or continu-
ous data that were not normally distributed. A weighted
statistic score and corresponding p values described by
Kosinski [11] were used to compare positive and nega-
tive predictive values. Statistical significance was defined
as a p value < 0.05.
Results
Patient characteristics
The final data set consisted of 71 patients who were
imaged using the multi-technique MCODE/LGE proto-
col. The enrolled patients represented a mixture of
patients with known coronary artery disease (CAD)
(54%) or intermediate to high likelihood of coronary dis-
ease with 30% (21 patients) having greater than three
TIMI risk factors. Fifty-two of the 71 patients were male,
and the mean age was 57.9 ± 11.1 years. Thirty-one per-
cent of the patients were specifically referred for assess-
ment of viability (including 12 acute and 10 chronic
MI’s), while another 52% were referred for assessment
of ischemia. The remaining patients were referred for
indications such as assessment for nonischemic cardiomy-
opathy (7 patients, 10%), aortic assessment (3 patients,
4%), and congenital assessment (2 patients, 3%).
Within the group, 46 patients were categorized with
MI (30 subendocardial and 16 transmural) and 25
patients without infarction. The 46 MI’s included 35patients who had outside confirmation of a clinical event
with a chest pain syndrome and cardiac enzyme abnor-
mality and nine patients who had evidence of Q waves
on EKG with angiographic evidence of CAD or an ab-
normal nuclear stress test. Two patients did not have a
prior history of MI but had fixed nuclear defects consist-
ent with MI.
Among the non-MI group, no one had a clinical his-
tory of an acute coronary syndrome nor evidence of Q
waves by EKG.
Compared to the patients without MI, the MI sub-
group of patients were more likely to have a prior his-
tory of CAD, hypertension, hyperlipidemia, and diabetes
and had lower ejection fractions. Baseline characteristics
are summarized in Table 1.
The mean time between contrast administration and
the LGE1 image was 11±5 min. The mean time between
contrast administration and the LGE2 image was 19±5
min. The mean time between the contrast and the
MCODE image was 20±5 min. On average, the MCODE
acquisition was performed 50 s after the LGE2 and 46 s
before the LGE3. The mean time between contrast ad-
ministration and the LGE3 image was 20±6 min. Figure 2
summarizes the timeline of the imaging protocol.
CMR findings
Diagnostic performance
Tables 2a-d and 3 illustrate the diagnostic performance
of each of the imaging techniques in identifying myocar-
dial infarction on a per patient basis. Both standard LGE
and MCODE performed well in the identification of MI.
MCODE had 100% sensitivity for the detection of MI
with no false negatives and 88% specificity against the
clinical definition of MI. LGE1 detected 38 of 46 patients
with MI (sensitivity 83%), but otherwise had the same
results as LGE2 and LGE3. LGE2 and LGE3 had identi-
cal results. LGE2 had a sensitivity of 85% because it
missed seven MI’s. The specificity of LGE2 was 92%.
Interestingly, the two LGE false positive MI’s were two of
the three patients labeled as false positive MI by MCODE.
MCODE had better sensitivity than LGE1 (p = 0.008),
LGE2 (p = 0.02), and LGE 3 (p = 0.02) but was not statis-
tically different in specificity.
LGE1, LGE2, LGE3, and MCODE identified all trans-
mural MI’s. All MI’s missed by LGE were in subendocar-
dial MI’s. When analyzing subendocardial MI, LGE1
images identified 22 of the 30 subendocardial MI’s, while
LGE2 and LGE3 images identified the presence of in-
farction in 23 of the 30 subendocardial MI’s. MCODE
identified 30 subendocardial infarctions.
Two patients had MI incorrectly identified by both
MCODE and LGE. One of the two patients had Q waves
in leads V1-V2 corresponding to a subendocardial ante-
roseptal region of LGE identified by both LGE and
Table 1 Baseline Patient Characteristics
Characteristic All patients n=71 MI n=46 No MI n=25 P value
Age - years
Mean ± standard deviation 57.9 ± 11.1 59.9 ± 9.9 54.2 ± 12.6 0.04
Maximum, minimum 28, 83 38, 83 28,80
Male sex – no (%) 52 (73) 35 (76) 17 (68) 0.47
CAD Risk Factors – no (%)
Family history 12 (17) 8 (17) 4 (16) 0.89
Hypertension 49 (69) 37 (80) 12 (48) 0.006
Dyslipidemia 49 (69) 40 (87) 9 (36) < 0.0001
Diabetes 15 (21) 14 (30) 1 (4) 0.012
Smoking 27 (38) 20 (57) 7 (28) 0.21
Known CAD – no (%) 38 (54) 37 (80) 1 (4) <0.0001
>3 CAD Risk Factors- no (%) 21 (30) 18 (39) 3 (12) 0.002
Medications (%)
Anti-platelets/anti coagulants
Aspirin 49 (69) 41 (89) 8 (32) <0.0001
Clopidogrel/Prasugrel 18 (25) 18 (39) 0 (0) 0.0004
Warfarin 4 (6) 3 (7) 1 (4) 0.69
Anti-hypertensives
Beta blocker 48 (68) 39 (85) 9 (36) <0.0001
Calcium channel blocker 8 (11) 5 (11) 3 (12) 0.89
ACE inhibitor 28 (39) 21 (46) 7 (28) 0.16
ARB 9 (13) 8 (17) 1 (4) 0.12
Diuretic 15 (21) 9 (20) 6 (24) 0.67
Long acting nitrates 6 (8) 6 (13) 0 (0) 0.08
Lipid Medications
Statin 44 (62) 38 (83) 6 (24) < 0.0001
Other lipid therapy 8 (11) 5 (11) 3 (12) 0.89
Diabetes Medications
Insulin 7 (10) 7 (15) 0 (0) 0.052
Oral diabetes agents 11 (16) 10 (22) 1 (4) 0.059
No Cardiovascular Medications 9 (13) 1 (2) 8 (32) 0.0002
Left ventricular ejection fraction %
Median, interquartile range 56, 15 51, 20 60,8 0.002
Indication for scan (%)
Ischemia Assessment with Stress 37 (52) 22 (48) 15 (60) 0.34
Viability 22 (31) 22 (48) 0 (0) <0.0001
Other 12 (17) 2 (4) 10 (40) 0.0002
Nonischemic cardiomyopathy 7 (10) 1 (2) 6 (24)
Aorta 3 (4) 1 (2) 2 (8)
Congenital 2 (3) 0 (0) 2 (8)
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defined MI or significant coronary artery disease in a left
anterior descending artery territory, and one patient had
no corroborating evidence of MI, by clinical history,
EKG, or other testing.
One MCODE false positive study did have angiographic
evidence of significant coronary artery disease in thecircumflex distribution and is displayed in Figure 3. On
the LGE T1 image on the left, there is no overt MI. When
one draws the subendocardial-blood pool border on the
T2 image on the right and copies it to the T1 image, then
one sees that what appears to be blood pool may actually
be a focal subendocardial region of LGE. There was a cor-
responding regional wall motion abnormality.
LGE1 LGE2 LGE3MCODE LGE T1 & T2 in
same acquisition
20±50
Timeline from administration of contrast (minutes)
11±5 20±619±5
Figure 2 Results: Timeline of image acquisition post-contrast: The mean time elapsed after contrast administration for each acquisition
is summarized.
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In sector-wise comparison of the two techniques,
MCODE detected 99 sectors of infarction compared to
83 sectors detected by LGE2 (p < 0.001). Figure 4 illus-
trates an example in which an overt subendocardial MI
of the anterolateral and inferolateral walls was identified
by the PSIR LGE technique. However, MCODE aided in
identifying an additional region of infarction within the
inferior wall (red arrow). The MCODE T2 image also
demonstrates that a similar small crevice adjacent to the
anterior wall is blood pool (yellow arrow).
Figure 5 displays a method of fusing the standard PSIR
LGE T1 image (first column) with the T2 image (second
column) to provide a composite image (third column)
using commercially available software (OsiriX, Geneva,
Switzerland). In the upper row, there is a clear cut sub-
endocardial MI which is easily identifiable on the PSIR
LGE image; MCODE does not add more information to
this case. In the lower row, there is poor blood-pool-to-
MI contrast. Use of the fused MCODE image providesTable 2 a-d: Diagnostic performance of each imaging
component in detecting MI: 2 × 2 contingency tables
a MI (+) MI (-)
MCODE (+) 46 3
MCODE (-) 0 22
b MI (+) MI (-)
LGE1 (+) 38 2
LGE1 (-) 8 23
c MI (+) MI (-)
LGE2 (+) 39 2
LGE2 (-) 7 23
d MI (+) MI (-)
LGE3 (+) 39 2
LGE3 (-) 7 23clearer identification of the extent of the subendocardial
MI along the anteroseptal and inferoseptal walls.
Comparison of signal intensities
On MCODE T1 imaging, the signal intensity differences
between MI and the blood pool were not statistically dif-
ferent (mean difference 16 arbitrary units (AU) ± 114,
p = 0.4). On the T2 imaging, the signal intensity differ-
ences between MI and the blood pool were significant
(mean difference 229 AU ± 70, p < 0.0001). In compar-
ing acute MI T2 signal intensity differences of infarcted
myocardium to blood pool against those of chronic
MI’s, there was no significant difference (p = 0.09).
Figure 6 demonstrates the different signal intensities be-
tween normal myocardium, MI, and the blood pool on
both the LGE T1 image and the T2 images acquired
with MCODE. Figure 7 displays the signal intensity
comparison for all patients between MCODE, LGE, T1,
and T2 images for blood vs. normal myocardium, MI vs.
blood, and MI vs. normal myocardium comparisons. As
hypothesized, there are significant differences between
blood and normal myocardium on both T1 and T2Table 3 Diagnostic performance of each imaging
component in detecting MI: Sensitivity, Specificity,
Positive Predictive Value, Negative Predictive Value
LGE1 LGE2 MCODE LGE3
Sensitivity* 83% 85% 100% 85%
Specificity** 92% 92% 88% 92%
Positive predictive value (PPV)** 95% 95% 94% 95%
Negative predictive value (NPV)* 75% 77% 100% 77%
Accuracy 86% 87% 96% 87%
*Sensitivity of LGE1 compared to MCODE, p = 0.008; NPV comparison,
p = 0.005.
*Sensitivity of LGE2/LGE3 compared to MCODE, p = 0.02; NPV comparison,
p = 0.009.
**Specificity and PPV of LGE1/LGE2/LGE3 compared to MCODE, p = not
statistically significant.
PSIR LGE T1 MCODE LGE T1 and T2
Figure 3 Example of an MCODE false positive MI: The above image is an example of one of MCODE’s false positive cases in a patient
with an 80% circumflex stenosis but no clinical history of an MI or evidence of Q waves by EKG.
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very little difference between MI and blood, but more of
a difference on the T2 images.
Discussion
MCODE, a method that acquires both a LGE image and
a T2-weighted image, improves detection of subendocar-
dial MI and assessment of the extent of infarction com-
pared with a conventional LGE image. While LGE and
MCODE were equivalent in transmural MI, MCODE
detected more subendocardial infarctions and found a
greater extent of infarctions than conventional LGE. The
main reason why MCODE improves the characterization
of MI relates to the simultaneous acquisition of T1-# 
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PSIR LGE T1
Figure 4 On a per sector basis, MCODE identified more infarcted sectweighted and T2-weighted images. Even in cases where
there is poor contrast between the MI and the blood
pool, the T2 image has excellent contrast between blood
and myocardium. Thus, the simultaneous acquisition of
LGE and T2-weighted images improves the ability to
differentiate subendocardial contrast-enhanced infarcts
because the T2-weighted image helps differentiate blood
from myocardium.
Good blood pool to infarct/scar contrast depends
upon multiple factors related to gadolinium kinetics:
gadolinium dose, elimination rate of contrast, time be-
tween contrast agent administration and imaging. Add-
itional factors that contribute to the ability to identify
regions of LGE include its size, the image spatialp < 0.001
T2
White=T1 data
Grey=T2 data
ors than LGE.
PSIR LGE T1 T2 FUSED PSIR-T2
S
u
b
je
ct
 1
S
u
b
je
ct
 2
Figure 5 Fusion of MCODE T1 and T2 data: DICOM images from MCODE sequences can be loaded into a free open source software,
OsiriX Imaging Software. From the MCODE sequence, the T2-weighted image is fused with the PSIR image with the Image Fusion function. No
manual registration of the images is necessary since they were acquired during the same breath hold. When fused, the grey-scale T2-weighted image
is then converted to the PET color look up table and overlays the grey-scale PSIR image. The image is then windowed and leveled to display areas
with low T2 signal intensity (myocardium) to appear as dark red, and areas with high T2 signal intensity (blood pool) to appear as bright yellow.
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solely one of allowing enough time to pass to allow more
clearance of gadolinium from the blood pool, then im-
aging at a later time frame after administration of con-
trast would solve the problem. Our study suggests that
the issue is not dominated by timing between contrast
injection and imaging. The bracketed LGE-MCODE-
LGE experiment demonstrates that contrast timing
washout does not explain why MCODE performs better
than standard LGE. However, whether LGE works better
at other time periods needs to be defined by future
studies.
Particularly in the assessment of viability, answering
the question of whether LGE is or is not present may
not be enough. Clearly delineating the extent of an in-
farction may aid in targeting what vessels to revascular-
ize. The patient displayed in Figure 4 had multi-vesselPSIR LGE T1 T2
Figure 6 Example comparison of LGE T1 and T2 signal intensity differ
example, LGE T1 signal intensities are similar between infarction and
myocardium have similar signal intensities but are different from the blood
border of the infarction is relative to the blood pool.disease with right coronary artery dominance, documen-
ted by angiography, and by the initial T1 images, he had
an overt anterolateral and inferolateral myocardial in-
farction, corresponding to the circumflex artery territory.
The inferior myocardial infarction, which was detected
only after using MCODE, corresponded to the right cor-
onary artery. Although LGE may identify that an MI is
present, MCODE not only adds confidence to the diag-
nosis, but it also may better identify the true extent of a
MI.
While the present study is limited to evaluating
patients with LGE in a MI pattern, there is prognostic
significance affiliated with abnormal LGE patterns of ei-
ther MI or atypical LGE. In a group of 857 patients with
complete CMR cine and LGE exams, Cheong et al.
demonstrated that abnormal LGE in both coronary ar-
tery disease and non-coronary artery disease patientsLGE T1 T2
Normal
Myocardium
188 ± 46 AU 532 ± 32 AU
Myocardial
Infarction
477 ± 130 AU 564 ± 65 AU
Blood Pool 551± 30 AU 829 ± 33 AU
ences between normal myocardium, blood, and MI: In this
blood. On the MCODE T2 image, both normal and infarcted
pool such that one can better differentiate where the endocardial
Blood vs. 
Normal
myocardium
MI vs. Blood MI vs. Normal 
myocardium
White=T1 data
Grey=T2 data
p<0.0001
p<0.0001
p<0.0001
p<0.0001
p<0.0001
p=0.4
Figure 7 Summary of signal intensity differences between blood, normal myocardium, and MI on LGE T1 and T2 images. On T1 images,
the MI to blood pool difference is not significant which can be diagnostically challenging. On the T2 images, there is a significant difference
between the MI and blood pool signal intensities.
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transplantation [12]. Appropriate identification of any
pattern of LGE may also assist in guiding management
of patients with cardiomyopathy, as demonstrated by the
study of Iles et al., in which 103 advanced cardiomyop-
athy patients underwent CMR imaging with gadolinium
prior to implantation of an implantable cardioverter de-
fibrillator. In one to two year follow-up, the study found
that all defibrillator discharges occurred in both ische-
mic and nonischemic cardiomyopathy patients with ab-
normal LGE; whereas, none of the patients without LGE
had any defibrillator discharges [13]. Kwong, et al. and
others demonstrated that unrecognized MI as documen-
ted by LGE predicted worse future outcomes [3,14].
Thus, accurate recognition of LGE in a patient can make
a clinical impact.
Limitations
While the study design was carried out in a rigorous
fashion, there were some limitations to the overall study.
One might argue that the SSFP cine image that is usu-
ally acquired in a complete CMR study could perform a
function similar to the T2-weighted image in the
MCODE image pair. This specific comparison was not
performed in the current study, and therefore, it is diffi-
cult to know if the MCODE approach is superior to
using the SSFP cine image without the direct compari-
son. However, multiple factors limit this comparison -
the SSFP image and the T1 LGE image are acquired on
separate breath-holds and at different time points, andthere are often significant differences in slice positions
or patient position, in temporal resolution and in trigger
times, to mention a few.
While the study design did directly compare the stand-
ard LGE technique to the MCODE technique at similar
times, the timing of the comparison was substantially
later than the initial LGE acquisition. Therefore, the per-
formance of MCODE, if applied at the same earlier time
point as the initial LGE imaging, is unknown. In theory,
at the earlier time point when the LGE blood-MI con-
trast is less, MCODE may have performed better.
A concern raised from this study’s findings might be
that the standard LGE technique did not perform as well
as expected compared to larger scale trials reporting the
sensitivity and specificity of LGE in the diagnosis of MI
[15]. However, it is important to note that only select
slices in question underwent the bracketed LGE-
MCODE-LGE design, and while on a specific slice com-
parison, the standard LGE technique may have missed
an MI, in the context of reviewing an entire stack of
LGE images with additional orthogonal views, the diag-
nostic performance of LGE likely improves. Further-
more, when comparing the current study’s performance
to that of the large, multi-center double-blinded rando-
mized trial assessing the performance of LGE using vari-
ous doses of gadolinium, the current study’s sensitivity
falls within the error bars of the 0.1 mmol/kg and the
0.2 mmol/kg doses’ performances.
Another recognized limitation is the fact that both
standard LGE techniques and MCODE perform well in
Bandettini et al. Journal of Cardiovascular Magnetic Resonance 2012, 14:83 Page 10 of 10
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the two techniques are difficult to detect in a study of
this relatively smaller size.
Conclusion
Our study demonstrates that in cases of subendocardial
MI, the T2 data acquired by the MCODE sequence adds
additional information to the final interpretation above
that of the data obtained in a PSIR LGE T1 image alone.
As more studies demonstrate the prognostic and clinical
decision-making impact that LGE has on patients, CMR
techniques need to also be able to more precisely iden-
tify LGE.
Abbreviations
AU: Arbitrary units; CMR: Cardiovascular Magnetic Resonance; FLASH: Fast
Low Angle Shot; Gd-DTPA: Gadolinium-diethylenetriamine pentaacetic acid;
LGE: Late gadolinium enhancement; LGE1: Initial late gadolinium
enhancement image; LGE2: Repeated late gadolinium enhancement image;
LGE3: Third late gadolinium enhancement image; MCODE: MultiContrast
Delayed Enhancement; MI: Myocardial infarction; NPV: Negative predictive
value; PSIR: Phase sensitive inversion recovery; PPV: Positive predictive value;
SD: Standard deviation.
Competing interests
Dr. Arai is principal investigator on a US Government Cooperative Research
and Development Agreement (CRADA) with Siemens.
Authors’ contributions
AEA, WPB, and PK conceived of the study design and actively worked to
coordinate details of the study, analysis of data, and drafting of the
manuscript. CM, MYC, OJB, SV, and JRW were involved in the acquisition of
data. SMS and SWL were involved in the acquisition of data and aided in
statistical analysis. All authors were involved in the final editing of the
manuscript and approve its content.
Acknowledgments
We would like to acknowledge our nurses Jennifer Henry, RN and Tracy
Lowrey, RN for their assistance in data collection and for their excellent
patient care. We would also like to acknowledge our MRI technologist
Pamela Vincent, RT for her assistance in patient scanning, Luis Rosario for his
efforts in compiling patient data, and Dr. Gang Chen for his statistical
expertise.
Funding
Supported by the intramural program, National Heart, Lung and Blood
Institute, National Institutes of Health.
Author details
1Advanced Cardiovascular Imaging Laboratory, Cardiovascular and
Pulmonary Branch, National Heart, Lung and Blood Institute (NHLBI), National
Institutes of Health (NIH), Department of Health and Human Services,
Bethesda, MD, USA. 2Johns Hopkins Suburban Hospital, Bethesda, MD, USA.
Received: 18 February 2012 Accepted: 27 September 2012
Published: 30 November 2012
References
1. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow
RO, Judd RM: The use of contrast-enhanced magnetic resonance imaging
to identify reversible myocardial dysfunction. N Engl J Med 2000,
343:1445–1453.
2. Kwon DH, Halley CM, Carrigan TP, Zysek V, Popovic ZB, Setser R,
Schoenhagen P, Starling RC, Flamm SD, Desai MY: Extent of left ventricular
scar predicts outcomes in ischemic cardiomyopathy patients with
significantly reduced systolic function: a delayed hyperenhancement
cardiac magnetic resonance study. JACC Cardiovasc Imaging 2009, 2:34–44.3. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, Davis RB:
Impact of unrecognized myocardial scar detected by cardiac magnetic
resonance imaging on event-free survival in patients presenting with
signs or symptoms of coronary artery disease. Circulation 2006,
113:2733–2743.
4. Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson CM,
Lesser JR, Hanna CA, Udelson JE, Manning WJ, Maron MS: Occurrence and
frequency of arrhythmias in hypertrophic cardiomyopathy in relation to
delayed enhancement on cardiovascular magnetic resonance. J Am Coll
Cardiol 2008, 51:1369–1374.
5. Kwon DH, Smedira NG, Rodriguez ER, Tan C, Setser R, Thamilarasan M, Lytle
BW, Lever HM, Desai MY: Cardiac magnetic resonance detection of
myocardial scarring in hypertrophic cardiomyopathy: correlation with
histopathology and prevalence of ventricular tachycardia. J Am Coll
Cardiol 2009, 54:242–249.
6. Bruder O, Wagner A, Jensen CJ, Schneider S, Ong P, Kispert EM, Nassenstein
K, Schlosser T, Sabin GV, Sechtem U, Mahrholdt H: Myocardial scar
visualized by cardiovascular magnetic resonance imaging predicts major
adverse events in patients with hypertrophic cardiomyopathy. J Am Coll
Cardiol 2010, 56:875–887.
7. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP,
Judd RM: An improved MR imaging technique for the visualization of
myocardial infarction. Radiology 2001, 218:215–223.
8. Schlosser T, Hunold P, Herborn CU, Lehmkuhl H, Lind A, Massing S,
Barkhausen J: Myocardial infarct: depiction with contrast-enhanced MR
imaging–comparison of gadopentetate and gadobenate. Radiology 2005,
236:1041–1046.
9. Kellman P, Chung YC, Simonetti OP, McVeigh ER, Arai AE: Multi-contrast
delayed enhancement provides improved contrast between myocardial
infarction and blood pool. J Magn Reson Imaging 2005, 22:605–613.
10. Kellman P, Arai AE, McVeigh ER, Aletras AH: Phase-sensitive inversion
recovery for detecting myocardial infarction using gadolinium-delayed
hyperenhancement. Magn Reson Med 2002, 47:372–383.
11. Kosinski AS: A weighted generalized score statistic for comparison of
predictive values of diagnostic tests. Stat Med 2012, doi:10.1002/sim.5587.
12. Cheong BY, Muthupillai R, Wilson JM, Sung A, Huber S, Amin S, Elayda MA,
Lee VV, Flamm SD: Prognostic significance of delayed-enhancement
magnetic resonance imaging: survival of 857 patients with and without
left ventricular dysfunction. Circulation 2009, 120:2069–2076.
13. Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, Taylor AJ:
Myocardial fibrosis predicts appropriate device therapy in patients with
implantable cardioverter-defibrillators for primary prevention of sudden
cardiac death. J Am Coll Cardiol 2011, 57:821–828.
14. Schelbert EB, Cao JJ, Sigurdsson S, Aspelund T, Kellman P, Aletras AH, Dyke
CK, Thorgeirsson G, Eiriksdottir G, Launer LJ, et al.: Prevalence and
prognosis of unrecognized myocardial infarction determined by cardiac
magnetic resonance in older adults. JAMA 2012, 308:890–896.
15. Kim RJ, Albert TS, Wible JH, Elliott MD, Allen JC, Lee JC, Parker M, Napoli A,
Judd RM: Performance of delayed-enhancement magnetic resonance
imaging with gadoversetamide contrast for the detection and
assessment of myocardial infarction: an international, multicenter,
double-blinded, randomized trial. Circulation 2008, 117:629–637.
doi:10.1186/1532-429X-14-83
Cite this article as: Bandettini et al.: MultiContrast Delayed Enhancement
(MCODE) improves detection of subendocardial myocardial infarction
by late gadolinium enhancement cardiovascular magnetic resonance: a
clinical validation study. Journal of Cardiovascular Magnetic Resonance
2012 14:83.
